Engene to participate in upcoming investor conferences

Boston & montreal--(business wire)--engene holdings inc. (nasdaq: engn or “engene” or the “company”), a clinical-stage, non-viral genetic medicines company, today announced that management will present at upcoming investor conferences in may 2025. details of the conferences are below: conference: 2025 bloom burton & co. healthcare investor conference date: monday, may 5, 2025 time: 2:30 p.m. et format: corporate presentation conference: the citizens life sciences conference date: wednesday,.
ENGN Ratings Summary
ENGN Quant Ranking